MEDVi vs PeterMD: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats PeterMD overall, scoring 7.7/10 vs 7.3/10. PeterMD is more affordable at $165/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .

A side-by-side comparison of MEDVi and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

PeterMD

#33 of 48

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Feature	MEDVi	PeterMD
Our Score	7.7/10	7.3/10
Starting Price	$299/mo	$165/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Budget-conscious users looking for the lowest monthly GLP-1 cost
Ranking	#22	#33

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

PeterMD

Pros

+Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
+Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
+Video consultations with physicians included — real face-to-face medical oversight

Cons

−Only available in 42 states — excluded from 8 states, limiting nationwide access
−Not BBB accredited, with some documented complaints about delayed medication fulfillment
−Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus

Our Verdict

MEDVi edges out PeterMD with a score of 7.7/10 vs 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to MEDVi's $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor PeterMD feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review